November 28, 2015
Recommended Topic Related To:


"The cystic fibrosis (CF) drug Orkambi (Vertex Pharmaceuticals) has received a green light from the European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP).

Orkambi is a fixed-dose oral combination "...



Included as part of the PRECAUTIONS section.




Deaths from anaphylaxis have been reported following IC-GREEN® administration during cardiac catheterization.

Drug Instability

IC-GREEN® is unstable in aque ous solution and must be use d within 6 hours. However, the dye is stable in plasma and whole blood so that samples obtained in discontinuous sampling techniques may be read hours later. Sterile techniques should be used in handling the dye solution as we ll as in the performance of the dilution curves. If a precipitate is present, discard the solution.

Drug/ Laboratory Test Interactions

Radioactive iodine uptake studies should not be performed for at least a week following the use of IC-GREEN™.

Carcinogenesis, Mutagenesis, Impairment Of Fertility

No studies have been performed to evaluate the carcinogenicity, mutagenicity, or impairment of fertility.

Use In Specific Populations


Animal Reproduction studies have not been con - ducted with IC-GREEN™. It is also not known whether IC-GREEN™ can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. IC-GREEN™ should be given to a pregnant woman only if clearly indicated.

Nursing Mothers

It is not known whether this drug is excreted in human milk. Because many drugs are excreted in human m ilk, caution should be exercised when IC -GREEN ™ is administered to a nursing woman.

Pediatric Use

Safety and effectiveness in pediatric patients have been established.

Geriatric Use

No overall differences in safety or effectiveness have been observed between elderly and younger patients.

This monograph has been modified to include the generic and brand name in many instances.

Last reviewed on RxList: 10/19/2015


Report Problems to the Food and Drug Administration


You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

Women's Health

Find out what women really need.

Use Pill Finder Find it Now See Interactions

Pill Identifier on RxList

  • quick, easy,
    pill identification

Find a Local Pharmacy

  • including 24 hour, pharmacies

Interaction Checker

  • Check potential drug interactions
Search the Medical Dictionary for Health Definitions & Medical Abbreviations